Home
Conditions
Myeloproliferative Disorders

Clinical trial condition

Myeloproliferative Disorders

Explore clinical trials studying Myeloproliferative Disorders. Study availability and eligibility vary by location and protocol.

47 public trials 10 recruiting studies

Refine in advanced search Browse all conditions

Myeloproliferative Disorders trial results

Recruiting

Preemptive CIML NK Cell Therapy After Hematopoietic Stem Cell Transplantation

NCT06138587

Conditions: Acute Myeloid Leukemia, Bone Marrow Diseases, Hematologic Diseases, +9 more
Locations: Dana-Farber Cancer Institute Boston, Massachusetts, United States

Brigham and Women's Hospital Boston, Massachusetts, United States

View Trial Details

Recruiting

Feasibility of a Multi-omics Platform for Hematological Malignancies

NCT07445438

Conditions: Acute Leukemia, Blood Protein Disorders, Bone Marrow Diseases, +19 more
Locations: University of Parma Parma, PR, Italy

View Trial Details

Recruiting

Chemogenomic Profiling in Hematological Malignancies (HEM-Profiling 2021)

NCT07445984

Conditions: Acute Leukemia, Bone Marrow Diseases, Chronic Leukemia, +8 more
Locations: University of Parma Parma, PR, Italy

View Trial Details

Recruiting

INTEGRATIVE "MULTI-OMICS" AND FUNCTIONAL PLATFORM FOR THE COMPLETE DIAGNOSTIC CHARACTERIZATION OF TUMORS: THE ITALIAN TUMOR CHEMOGENOMIC PROFILER (IT-TCP)

NCT07403630

Conditions: Acute Leukemia, Adenoma, Adnexal Diseases, +73 more
Locations: AO Riuniti Villa Sofia-Cervello di Palermo Palermo, Italy

University of Perugia Perugia, Italy

View Trial Details

Recruiting

MPN PROGRESSion Registry: Observational Study Tracking Symptoms, Treatments, and Disease Progression in People With Myeloproliferative Neoplasms (MPNs)

NCT07362225

Conditions: Accelerated Phase MPN, Accelerated Phase Myeloproliferative Neoplasm, Agnogenic Myeloid Metaplasia, +78 more
Locations: MPN Research Foundation Chicago, Illinois, United States

Memorial Sloan Kettering Cancer Center New York, United States

View Trial Details

Recruiting

Prognostic Value of NETosis Markers for Thrombosis During Myeloproliferative Neoplasms (AVATARE)

NCT07119970

Conditions: Bone Marrow Diseases, Cardiovascular Diseases, Embolism and Thrombosis, +6 more
Locations: CHU d'Angers, Service des maladies du Sang Angers, France

CH de la Côte Basque, Service Hématologie Bayonne, France

CHU de Bordeaux, Service Hématologie Biologique Bordeaux, France

CHU de Bordeaux, Service Hématologie Clinique et Thérapie Cellulaire Bordeaux, France

View all 15 locations

View Trial Details

Recruiting

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

NCT03452774

Conditions: Adenocarcinoma, Adnexal Diseases, Astrocytoma, +144 more
Locations: Massive Bio SYNERGY-AI site Birmingham, Alabama, United States

Massive Bio SYNERGY-AI site Mobile, Alabama, United States

Massive Bio SYNERGY-AI site Scottsdale, Arizona, United States

Massive Bio SYNERGY-AI site Little Rock, Arkansas, United States

View all 68 locations

View Trial Details

Recruiting

Trial of 2 Step ATG for Prevention of Acute GVHD Post Allogeneic Stem Cell Transplant

NCT06265584

Conditions: Acute Leukemia, Bone Marrow Diseases, Hematologic Diseases, +7 more
Locations: University of Alabama at Birmingham Birmingham, Alabama, United States

View Trial Details

Recruiting

Trial of 2 Step ATG for Acute GVHD Prevention Post Myeloablative Allogeneic Stem Cell Transplant

NCT06315309

Conditions: Acute Leukemia, Bone Marrow Diseases, GVHD,Acute, +7 more
Locations: University of Alabama at Birmingham Birmingham, Alabama, United States

View Trial Details

Recruiting

I Can Move With Purpose Now! A Pilot Lifestyle Intervention Study in Myeloproliferative Neoplasm Patients

NCT05842603

Conditions: Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +4 more
Locations: Brigham and Women's Hospital Boston, Massachusetts, United States

Dana-Farber Cancer Institute Boston, Massachusetts, United States

Massachusetts General Hospital Cancer Center Boston, Massachusetts, United States

View Trial Details

Myeloproliferative Disorders

Myeloproliferative Disorders trial results

Related conditions